Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans.
JAMA Cardiol
; 2(10): 1164-1166, 2017 10 01.
Article
in En
| MEDLINE
| ID: mdl-28903137
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
PCSK9 Inhibitors
/
Antibodies, Monoclonal
/
Anticholesteremic Agents
Type of study:
Health_economic_evaluation
Limits:
Adult
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
JAMA Cardiol
Year:
2017
Document type:
Article